| Breast Cancer |
1 |
1 |
| Dietary Supplements |
0 |
1 |
| Sleep |
0 |
0.9 |
| Cancer |
0 |
0.57 |
| Night Sweats |
0 |
0.49 |
| Breast |
0 |
0.42 |
| Breast Disorder |
0 |
0.29 |
| Depression |
0 |
0.26 |
| Selective Estrogen Receptor Modulators |
0 |
0.2 |
| Sleep Disorders |
0 |
0.9 |
| Hormonal Therapy |
0 |
1 |
| Patient Safety |
0 |
0.16 |
| Receptors |
0 |
0.16 |
| Adverse Effects |
0 |
0.1 |
| Estrogen |
0 |
0.1 |
| Rheumatoid Arthritis |
0 |
0.09 |
| Anxiety Disorder |
0 |
0.07 |
| Cardiovascular Risk Management |
0 |
0.07 |
| Epilepsy |
0 |
0.07 |
| Menopause |
0 |
0.07 |
| Anticonvulsant |
0 |
0.05 |
| Anxiety |
0 |
0.05 |
| Arthritis |
0 |
0.05 |
| Brain |
0 |
0.05 |
| Cardiovascular disease |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Fatty Acids |
0 |
1 |
| Hospital |
0 |
0.05 |
| Mood Disorders |
0 |
0.9 |
| Peer Review |
0 |
0.05 |
| Preventive Screening |
0 |
0.05 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.05 |